PLAU and neoplasm: Human tumors with high mRNA levels of PLAU, which encodes the urokinase-type plasminogen activator (uPA), a key activator of plasminogen, have a dense tumor infiltrate of monocytes–macrophages and express high levels of important regulatory immune molecules, such as the immune checkpoint CD276/B7-H3 [7].